查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946499

施馬倫貝格病毒治療市場 - 全球產業規模、佔有率、趨勢、機會及預測（按治療類型、動物類型、地區和競爭格局分類，2021-2031年）

Schmallenberg Virus Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Animal Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球施馬倫貝格病毒治療市場預計將從 2025 年的 1.4767 億美元成長到 2031 年的 2.3485 億美元，複合年成長率為 8.04%。

該市場領域涵蓋獸醫干預措施，包括疫苗接種、診斷設備和支持性護理，旨在減輕正布尼亞病毒對反芻家畜的有害影響。推動該市場成長的主要因素是迫切需要避免因牛出生缺陷和死胎造成的嚴重經濟損失。此外，人們對動物福利的日益關注以及在流行地區實施綜合畜牧健康策略的需求，也持續推動對有效應對措施的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 1.4767億美元
市場規模：2031年 2.3485億美元
複合年成長率：2026-2031年 8.04%
成長最快的細分市場 支持性護理
最大的市場 北美洲

高額損失凸顯了該市場的緊迫性：2024年，國家綿羊委員會報告稱，在受災嚴重的地區，早期產羔羊群的羔羊損失率高達10%至25%，這凸顯了可靠管理解決方案的必要性。儘管需求強勁，但由於病毒爆發的間歇性和週期性，市場成長面臨許多障礙。這種不可預測性導致收入來源不穩定，並使藥物研發者的長期生產計畫變得複雜，往往阻礙了對新治療方法研發的持續投資。

市場促進因素

施馬倫貝格病毒在牲畜中的發生率不斷上升，是推動市場擴張的主要因素，也因此對診斷和管理資源的需求即時。由於病毒呈現週期性復發，先天性畸形和死胎的突然增加，使得獸醫必須迅速採取行動，控制病毒傳播，維護畜群健康。根據AgriLand 2025年2月的報告，2024年愛爾蘭確診病例數較去年激增2,200%。這一快速成長凸顯了該疾病的變異性，以及在感染高峰期提供及時治療方案的重要性。該病原體對多種反芻動物的影響也顯而易見，《愛爾蘭農民日誌》報道稱，2025年有12個牛的檢測結果呈陽性。

此外，為最大限度減少生產損失，生產者不得不投資有效的治療和支持性護理措施。難產、獸醫服務以及可售牲畜損失所帶來的成本，促使農民實施嚴格的衛生通訊協定以保障利潤。一項發表於2025年8月《獸醫檔案》的研究，聚焦於2023-2024年英國羔羊產季，發現44個受感染的農場在財務穩定性和羊群福利方面受到的負面影響顯著大於未受影響的農場。這些財務壓力迫使生產者採取強化監測和應對策略，而減輕對農場盈利的損害對於維持受影響地區的反芻動物生產系統至關重要。

市場挑戰

全球施馬倫貝格病毒治療市場的擴張受到其零星且週期性爆發模式的顯著阻礙。與需要定期年度治療的疾病不同，這種正布尼亞病毒的傳播率受媒介活動和群體免疫的影響，呈現不穩定的波動性，導致需求激增期與長期市場停滯期交替出現。這種不可預測性使得製藥公司難以預測收入，也難以合理安排研發和生產新療法所需的大量資本投入。

因此，相關人員在庫存管理方面面臨重大風險，經常在需求高峰期出現缺貨，而在需求低迷期則造成產品浪費。英國全國農民聯盟的一份報告凸顯了這種波動性，該報告指出，2024年初，病毒在英國畜牧業突然捲土重來，短短六週內就確診了63例病例，這表明典型的疫情爆發週期為三到五年。這種波動性阻礙了先進醫療解決方案的長期研發，因為企業往往更傾向於穩定的市場而非週期性市場。

市場趨勢

快速現場診斷試劑盒正日益普及，為畜牧生產者提供便利，避免了集中檢測固有的物流延誤。如果沒有即時的現場確認，農民在零星疫情爆發期間將面臨不確定性，這不僅阻礙了受感染動物的快速隔離，也使畜群管理變得更加複雜。現有檢測設施日益成長的壓力凸顯了這個問題。根據 Agriland 2025 年 2 月報道，在 2024 年的監測期內，愛爾蘭農業、林業和漁業部 (DAFM) 不得不分析 369牛和 84 隻羊的檢體，以確認病毒的存在。這種對外部檢測的嚴重依賴正在推動市場對即時的現場病原體檢測工具的需求，從而縮短從懷疑到應對的時間。

同時，施馬倫貝格病毒與其他蠓蟲傳播疾病（例如藍探戈病毒）的地理分佈重疊，推動了多價疫苗和聯合疫苗的快速研發。製藥公司正優先開發頻譜疫苗製劑，以提供雙重保護，從而有效降低反芻動物群接種不同疫苗的工作量和成本。多種病毒同時威脅的規模凸顯了市場對這類綜合解決方案的需求。根據愛爾蘭農業食品發展局（Teagasc）2025年1月發布的最新數據，2024年荷蘭超過1萬個地點被檢測出藍探戈病毒呈陽性，這凸顯了採取聯合預防策略以應對歐洲各地通用蟲媒傳播疾病問題的必要性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5.全球Schmallenberg病毒治療市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依治療類型（支持性治療、病媒控制、預防措施）
    • 依動物種類（牛、羊、山羊）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美施馬倫貝格病毒治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲施馬倫貝格病毒治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區施馬倫貝格病毒治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東與非洲施馬倫貝格病毒治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲施馬倫貝格病毒治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第 13 章：全球 Schmallenberg 病毒治療市場：SWOT 分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boehringer Ingelheim International GmbH
  • Zoetis
  • MSD Animal Health
  • Elanco Animal Health
  • Neogen Corporation
  • Heska Corporation
  • Phibro Animal Health
  • IDT Biologika
  • Phibro Animal Health
  • Dechra Pharmaceuticals

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19886

The Global Schmallenberg Virus Treatment Market is projected to expand from USD 147.67 Million in 2025 to USD 234.85 Million by 2031, registering a CAGR of 8.04%. This market sector comprises veterinary interventions, including preventive vaccinations, diagnostic instruments, and supportive care therapies aimed at reducing the Orthobunyavirus's detrimental effects on ruminant livestock. Growth is primarily propelled by the critical necessity to avert severe financial setbacks caused by congenital defects and stillbirths within cattle and sheep populations. Furthermore, the rising emphasis on animal welfare and the requirement for comprehensive herd health strategies in endemic areas continue to drive the demand for efficient control measures.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 147.67 Million
Market Size 2031USD 234.85 Million
CAGR 2026-20318.04%
Fastest Growing SegmentSupportive Care
Largest MarketNorth America

High-impact losses underscore the urgency of this market; the National Sheep Association noted in 2024 that early lambing flocks in hard-hit regions suffered lamb losses ranging from 10% to 25%, emphasizing the need for dependable management solutions. Despite this strong demand, market growth faces a significant hurdle due to the sporadic and cyclical nature of viral outbreaks. This unpredictability creates unstable revenue streams and complicates long-term production planning for pharmaceutical developers, often discouraging sustained investment in the creation of new therapeutic options.

Market Driver

The rising frequency of Schmallenberg virus outbreaks in livestock serves as a major engine for market expansion, generating an immediate need for diagnostic and management resources. As the virus returns in cyclical waves, the sudden spike in congenital malformations and stillbirths requires prompt veterinary action to limit transmission and maintain herd health. According to an Agriland report from February 2025, the number of confirmed cases in Ireland surged by 2,200% in 2024 compared to the previous year. This sharp increase highlights the disease's volatility and the vital importance of having treatment options readily available during infection peaks, while the pathogen's impact on various ruminants is evidenced by the Irish Farmers Journal reporting 12 cattle herds testing positive in 2025.

Moreover, the economic necessity of minimizing production losses pushes producers to fund effective treatment and supportive care measures. The costs associated with difficult births, veterinary services, and the loss of marketable offspring compel farm managers to implement strict health protocols to safeguard their profits. A study published in the Veterinary Record in August 2025, focusing on the 2023-2024 UK lambing season, revealed that 44 farms with confirmed infections faced considerably greater negative impacts on financial stability and flock welfare than unaffected farms. These financial strains necessitate the use of thorough surveillance and response strategies, as reducing the damage to farm profitability is crucial for maintaining ruminant production systems in affected regions.

Market Challenge

The expansion of the Global Schmallenberg Virus Treatment Market is significantly hindered by the sporadic and cyclical pattern of outbreaks. Unlike diseases that demand regular, annual treatments, this Orthobunyavirus demonstrates a volatile transmission rate influenced by vector activity and herd immunity, resulting in phases of intense demand followed by long periods of market inactivity. This unpredictability makes it extremely difficult for pharmaceutical manufacturers to predict revenue or rationalize the heavy capital investment needed for researching and producing new therapeutics.

As a result, stakeholders encounter major risks regarding inventory control, frequently facing stock shortages during spikes or product wastage during quiet periods. This instability is highlighted by the National Farmers Union, which reported a sudden viral resurgence in the UK livestock sector in early 2024, with 63 confirmed cases occurring over just six weeks, indicative of the typical three-to-five-year outbreak cycle. Such erratic fluctuations discourage long-term commitment to developing advanced medical solutions, as companies tend to favor stable markets over those characterized by boom-and-bust cycles.

Market Trends

There is a growing trend toward adopting rapid point-of-care diagnostic kits as livestock producers look to avoid the logistical delays inherent in centralized reference laboratories. Without immediate on-site confirmation, farmers deal with uncertainty during sporadic outbreaks, which impedes the quick isolation of infected animals and complicates herd management. The strain on existing testing facilities highlights this issue; as noted by Agriland in February 2025, the Department of Agriculture, Food and the Marine (DAFM) had to analyze 369 cattle and 84 sheep samples to confirm the virus's presence during the 2024 surveillance period. This heavy reliance on off-site testing is driving the market toward field-ready tools capable of real-time pathogen detection, thereby shortening the time between suspicion and action.

Concurrently, the development of multivalent and combination vaccines is being fast-tracked due to the overlapping geographic presence of the Schmallenberg virus and other midge-borne diseases like Bluetongue. Pharmaceutical developers are increasingly prioritizing broad-spectrum formulations to offer dual protection, effectively lowering the labor and costs involved in administering separate vaccines to ruminant herds. The market's need for such integrated solutions is emphasized by the magnitude of simultaneous viral threats; according to a Teagasc update in January 2025, the Netherlands reported over 10,000 Bluetongue-positive locations in 2024, presenting a strong argument for combined prophylactic strategies to tackle the shared vector challenge across European regions.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Zoetis
  • MSD Animal Health
  • Elanco Animal Health
  • Neogen Corporation
  • Heska Corporation
  • Phibro Animal Health
  • IDT Biologika
  • Phibro Animal Health
  • Dechra Pharmaceuticals

Report Scope

In this report, the Global Schmallenberg Virus Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Schmallenberg Virus Treatment Market, By Treatment Type

  • Supportive Care
  • Vector Control
  • Preventive Measures

Schmallenberg Virus Treatment Market, By Animal Type

  • Cattle
  • Sheep
  • Goats

Schmallenberg Virus Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Schmallenberg Virus Treatment Market.

Available Customizations:

Global Schmallenberg Virus Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Schmallenberg Virus Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment Type (Supportive Care, Vector Control, Preventive Measures)
    • 5.2.2. By Animal Type (Cattle, Sheep, Goats)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Schmallenberg Virus Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment Type
    • 6.2.2. By Animal Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Schmallenberg Virus Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment Type
        • 6.3.1.2.2. By Animal Type
    • 6.3.2. Canada Schmallenberg Virus Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment Type
        • 6.3.2.2.2. By Animal Type
    • 6.3.3. Mexico Schmallenberg Virus Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment Type
        • 6.3.3.2.2. By Animal Type

7. Europe Schmallenberg Virus Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment Type
    • 7.2.2. By Animal Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Schmallenberg Virus Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment Type
        • 7.3.1.2.2. By Animal Type
    • 7.3.2. France Schmallenberg Virus Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment Type
        • 7.3.2.2.2. By Animal Type
    • 7.3.3. United Kingdom Schmallenberg Virus Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment Type
        • 7.3.3.2.2. By Animal Type
    • 7.3.4. Italy Schmallenberg Virus Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment Type
        • 7.3.4.2.2. By Animal Type
    • 7.3.5. Spain Schmallenberg Virus Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment Type
        • 7.3.5.2.2. By Animal Type

8. Asia Pacific Schmallenberg Virus Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment Type
    • 8.2.2. By Animal Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Schmallenberg Virus Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment Type
        • 8.3.1.2.2. By Animal Type
    • 8.3.2. India Schmallenberg Virus Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment Type
        • 8.3.2.2.2. By Animal Type
    • 8.3.3. Japan Schmallenberg Virus Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment Type
        • 8.3.3.2.2. By Animal Type
    • 8.3.4. South Korea Schmallenberg Virus Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment Type
        • 8.3.4.2.2. By Animal Type
    • 8.3.5. Australia Schmallenberg Virus Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment Type
        • 8.3.5.2.2. By Animal Type

9. Middle East & Africa Schmallenberg Virus Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment Type
    • 9.2.2. By Animal Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Schmallenberg Virus Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment Type
        • 9.3.1.2.2. By Animal Type
    • 9.3.2. UAE Schmallenberg Virus Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment Type
        • 9.3.2.2.2. By Animal Type
    • 9.3.3. South Africa Schmallenberg Virus Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment Type
        • 9.3.3.2.2. By Animal Type

10. South America Schmallenberg Virus Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment Type
    • 10.2.2. By Animal Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Schmallenberg Virus Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment Type
        • 10.3.1.2.2. By Animal Type
    • 10.3.2. Colombia Schmallenberg Virus Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment Type
        • 10.3.2.2.2. By Animal Type
    • 10.3.3. Argentina Schmallenberg Virus Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment Type
        • 10.3.3.2.2. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Schmallenberg Virus Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Zoetis
  • 15.3. MSD Animal Health
  • 15.4. Elanco Animal Health
  • 15.5. Neogen Corporation
  • 15.6. Heska Corporation
  • 15.7. Phibro Animal Health
  • 15.8. IDT Biologika
  • 15.9. Phibro Animal Health
  • 15.10. Dechra Pharmaceuticals

16. Strategic Recommendations

17. About Us & Disclaimer